Torben Redmer

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironment.

Correction: Cell‑autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53‑driven senescence and confers an immune‑active tumor microenvironment.

Journal: Molecular cancer

Published: July 07, 2026

Half a century of gene expression analysis : The path to modern spatial transcriptomics in autopsy tissue

Half a century of gene expression analysis : The path to modern spatial transcriptomics in autopsy tissue

Journal: Pathologie (Heidelberg, Germany)

Published: November 08, 2025

Transcriptional adaptation of rumen papillae to high-grain diet reveals distinct temporal phases and SARA susceptibility signatures.

Transcriptional adaptation of rumen papillae to high-grain diet reveals distinct temporal phases and SARA susceptibility signatures.

Journal: Journal of animal science and biotechnology

Published: October 17, 2025

Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth.

Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth.

Journal: Molecular cancer

Published: April 14, 2025

The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer.

The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer.

Journal: Molecular cancer

Published: June 24, 2024

Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases.

Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases.

Journal: The Journal of investigative dermatology

Published: May 07, 2024

Correction to: MET receptor serves as a promising target in melanoma brain metastases.

Correction to: MET receptor serves as a promising target in melanoma brain metastases.

Journal: Acta neuropathologica

Published: March 27, 2024

Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.

Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironment.

Journal: Molecular cancer

Published: March 17, 2024

JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.

JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.

Journal: Molecular cancer

Published: November 29, 2023

MET receptor serves as a promising target in melanoma brain metastases.

MET receptor serves as a promising target in melanoma brain metastases.

Journal: Acta neuropathologica

Published: October 16, 2023

Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.

Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.

Journal: Cancers

Published: June 24, 2022

Decoding molecular programs in melanoma brain metastases.

Decoding molecular programs in melanoma brain metastases.

Journal: Nature communications

Published: February 16, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026